Ashland Global Holdings Inc ASH
We take great care to ensure that the data presented and summarized in this overview for ASHLAND GLOBAL HOLDINGS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ASH
View all-
Vanguard Group Inc Valley Forge, PA4.86MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$320 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.77MShares$198 Million0.06% of portfolio
-
Eminence Capital, LP New York, NY2.65MShares$189 Million3.48% of portfolio
-
Massachusetts Financial Services CO Boston, MA2.6MShares$186 Million0.07% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH1.93MShares$138 Million0.71% of portfolio
-
Allspring Global Investments Holdings, LLC1.74MShares$124 Million0.24% of portfolio
-
Clearbridge Investments, LLC New York, NY1.67MShares$119 Million0.12% of portfolio
-
State Street Corp Boston, MA1.52MShares$108 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY981KShares$70.1 Million0.01% of portfolio
Latest Institutional Activity in ASH
Top Purchases
Top Sells
About ASH
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
Insider Transactions at ASH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 05
2024
|
Eric N Boni VP, Finance & Prinpl Acctg Off |
SELL
Open market or private sale
|
Direct |
451
-3.08%
|
$35,178
$78.07 P/Share
|
Dec 04
2024
|
Eric N Boni VP, Finance & Prinpl Acctg Off |
BUY
Exercise of conversion of derivative security
|
Direct |
451
+2.99%
|
$26,609
$59.95 P/Share
|
Nov 19
2024
|
Guillermo Novo Chair of the Board and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,644
-3.53%
|
$352,944
$76.39 P/Share
|
Nov 19
2024
|
Guillermo Novo Chair of the Board and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,096
+7.79%
|
$843,296
$76.39 P/Share
|
Nov 19
2024
|
J Kevin Willis SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,608
-0.69%
|
$122,208
$76.39 P/Share
|
Nov 19
2024
|
J Kevin Willis SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,486
+1.47%
|
$264,936
$76.39 P/Share
|
Nov 19
2024
|
Eric N Boni VP, Finance & Prinpl Acctg Off |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.91%
|
$9,880
$76.39 P/Share
|
Nov 19
2024
|
Eric N Boni VP, Finance & Prinpl Acctg Off |
BUY
Exercise of conversion of derivative security
|
Direct |
450
+3.05%
|
$34,200
$76.39 P/Share
|
Nov 19
2024
|
Eileen Drury SVP and Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-6.8%
|
$34,124
$76.39 P/Share
|
Nov 19
2024
|
Eileen Drury SVP and Chief HRO |
BUY
Exercise of conversion of derivative security
|
Direct |
911
+12.12%
|
$69,236
$76.39 P/Share
|
Nov 19
2024
|
Karl R. Bostaph Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-2.14%
|
$11,628
$76.39 P/Share
|
Nov 19
2024
|
Karl R. Bostaph Senior VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
418
+5.51%
|
$31,768
$76.39 P/Share
|
Nov 19
2024
|
Osama M Musa SVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
679
-2.49%
|
$51,604
$76.39 P/Share
|
Nov 19
2024
|
Osama M Musa SVP and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,878
+6.44%
|
$142,728
$76.39 P/Share
|
Nov 19
2024
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
SELL
Open market or private sale
|
Direct |
162
-4.61%
|
$12,150
$75.54 P/Share
|
Nov 19
2024
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-3.43%
|
$9,500
$76.39 P/Share
|
Nov 19
2024
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
BUY
Exercise of conversion of derivative security
|
Direct |
418
+10.3%
|
$31,768
$76.39 P/Share
|
Nov 18
2024
|
J Kevin Willis SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,780
-0.38%
|
$137,060
$77.03 P/Share
|
Nov 18
2024
|
J Kevin Willis SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,860
+0.83%
|
$297,220
$77.03 P/Share
|
Nov 18
2024
|
Eric N Boni VP, Finance & Prinpl Acctg Off |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-0.53%
|
$11,396
$77.03 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 83.9K shares |
---|
Payment of exercise price or tax liability | 34.1K shares |
---|---|
Open market or private sale | 7.81K shares |